Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

MSGV-1D3-28Z All ITAMs intact Citations (4)

Originally described in: Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells.
Kochenderfer JN, Yu Z, Frasheri D, Restifo NP, Rosenberg SA Blood. 2010 Nov 11;116(19):3875-86. doi: 10.1182/blood-2010-01-265041. Epub 2010 Jul 14.
PubMed Journal

Articles Citing MSGV-1D3-28Z All ITAMs intact

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. Daniels J, Doukas PG, Escala MEM, Ringbloom KG, Shih DJH, Yang J, Tegtmeyer K, Park J, Thomas JJ, Selli ME, Altunbulakli C, Gowthaman R, Mo SH, Jothishankar B, Pease DR, Pro B, Abdulla FR, Shea C, Sahni N, Gru AA, Pierce BG, Louissaint A Jr, Guitart J, Choi J. Nat Commun. 2020 Apr 14;11(1):1806. doi: 10.1038/s41467-020-15572-7. PubMed
Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19. Fioretti S, Matson CA, Rosenberg KM, Singh NJ. Cancer Immunol Immunother. 2022 Jun 26. pii: 10.1007/s00262-022-03231-3. doi: 10.1007/s00262-022-03231-3. PubMed
Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity. Sanchez-Paulete AR, Mateus-Tique J, Mollaoglu G, Nielsen SR, Marks A, Lakshmi A, Khan JA, Wilk CM, Pia L, Baccarini A, Merad M, Brown BD. Cancer Immunol Res. 2022 Nov 2;10(11):1354-1369. doi: 10.1158/2326-6066.CIR-21-1075. PubMed
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology. Lontos K, Wang Y, Colbert M, Kumar A, Joshi S, Philbin M, Wang Y, Frisch A, Lohmueller J, Rivadeneira DB, Delgoffe GM. Oncoimmunology. 2022 Oct 18;11(1):2131229. doi: 10.1080/2162402X.2022.2131229. eCollection 2022. PubMed

Associated Plasmids

If you have published an article using this material, please email us at [email protected] to have your article added to this page.